Disparities in high fasting plasma glucose-related cardiovascular disease burden in China

Xue Cao, Yixin Tian, Zhenping Zhao, Limin Wang, Xin Wang, Congyi Zheng, Zhen Hu, Runqing Gu, Xue Yu, Xuyan Pei, Peng Yin, Yuna He, Yuehui Fang, Mei Zhang, Maigeng Zhou () and Zengwu Wang ()
Additional contact information
Xue Cao: Peking Union Medical College& Chinese Academy of Medical Sciences
Yixin Tian: Peking Union Medical College& Chinese Academy of Medical Sciences
Zhenping Zhao: Chinese Center for Disease Control and Prevention
Limin Wang: Chinese Center for Disease Control and Prevention
Xin Wang: Peking Union Medical College& Chinese Academy of Medical Sciences
Congyi Zheng: Peking Union Medical College& Chinese Academy of Medical Sciences
Zhen Hu: Peking Union Medical College& Chinese Academy of Medical Sciences
Runqing Gu: Peking Union Medical College& Chinese Academy of Medical Sciences
Xue Yu: Peking Union Medical College& Chinese Academy of Medical Sciences
Xuyan Pei: Peking Union Medical College& Chinese Academy of Medical Sciences
Peng Yin: Chinese Center for Disease Control and Prevention
Yuna He: Chinese Center for Disease Control and Prevention
Yuehui Fang: Chinese Center for Disease Control and Prevention
Mei Zhang: Chinese Center for Disease Control and Prevention
Maigeng Zhou: Chinese Center for Disease Control and Prevention
Zengwu Wang: Peking Union Medical College& Chinese Academy of Medical Sciences

Nature Communications, 2024, vol. 15, issue 1, 1-10

Abstract: Abstract Elaborating and understanding disparities in the burden of cardiovascular disease attributable to high fasting plasma glucose is important to improve diabetes prevention and promote cardiovascular health. In this study, we pool data on 791,373 people aged 25 years and older from three population-based surveys, and estimate the burden of cardiovascular disease attributable to high fasting plasma glucose between 2010 and 2018 in China by age, sex, region and socio-demographic index. In 2018, an estimated total of 498.61 thousand (95% uncertainty interval 463.93 to 534.12) cardiovascular disease-related deaths are attributable to high fasting plasma glucose in China. High fasting plasma glucose accounts for 1076.09 years of life lost per 100,000 people (95% uncertainty interval 1026.88–1129.04) due to cardiovascular disease in 2018, with substantial variation across provinces. In 2018, the higher age-standardised cardiovascular disease mortality rate attributable to high fasting plasma glucose is observed in the high-middle socio-demographic index region and the middle socio-demographic index region. Nationally, compared to 2010, exposure to high fasting plasma glucose and population aging in 2018 are the primary drivers of increased fasting plasma glucose-related deaths due to cardiovascular disease. Findings of this study emphasize the importance of developing population-specific tailored measures in China and other regions with similar condition.

Date: 2024
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-024-53236-y Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-53236-y

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-024-53236-y

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().